)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Pharmanutra
Pharmanutra (PHN) investor relations material
Pharmanutra Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary9 Nov, 2026
Executive summary
9M 2026 net revenues rose 17.3% to €110.934M; total revenues increased 17.9% to €112.834M, EBITDA rose 17.3% to €29.099M and net result reached €16.980M.
AS IS revenue grew 14.2%, while New Business Units contributed €7.203M, up 90.4% YoY.
International revenue rose 33.5% to €44.4M, or 40.0% of total; finished-product volumes increased 22.2% to 13.7M units.
Financial highlights
Net revenues were €110.934M versus €94.604M; other revenues were €1.900M, bringing total revenues to €112.834M versus €95.680M.
EBITDA increased to €29.099M from €24.809M; EBIT was €25.458M versus €22.104M, and pre-tax result was €25.4M versus €22.0M.
Group net profit rose 21.2% to €16.980M from €14.009M; EPS increased to €1.78 from €1.46.
Operating expenses grew 18.2% to €83.735M, including ~€10M of New Business Unit marketing, logistics and commercial investment.
Outlook and guidance
2026 outlook anticipates growth in AS IS revenues in Italy and foreign markets, plus significant New Business Unit growth, driven by the US and China.
EBITDA margin is expected to improve, with operating investments supporting New Business Units; strong cash generation is expected.
October US net revenues exceeded $500K; innovative product launches are scheduled for 2027.
Ongoing geopolitical conflicts are not expected to have a significant impact on performance.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Pharmanutra
- Proprietary health technologies and 81-country reach anchor a science-led portfolio.PHN
Company presentation - New business units lift projected 2022–2030 sales CAGR to 18.5% and profitability CAGR to 20.4%.PHNInvestor Day 2023 presentation
- Strong global growth and innovation, with surging revenues and expanding product lines.PHNCorporate presentation
- Net revenues up 17.9% to €73M, driven by international and new business unit growth.PHNH1 2026
- H1 2024 delivered 13% sales growth, 23% higher net result, and robust international expansion.PHNH1 2024
- Q1 2026 saw 24.5% revenue growth and 41.9% profit rise, driven by global and segment expansion.PHNQ1 2026
- Revenue and profit surged on robust global sales and new launches, with further growth expected.PHNQ3 2024
- Net revenues up 11.2% to €26.4M, with stable EBITDA and strong international growth.PHNQ1 2025
- H1 2025 revenues grew 10.4% to €61.9M, with net profit up 3.2% to €9.2M and margins slightly down.PHNH1 2025
Next Pharmanutra earnings date
Q4 202615 Mar, 2027
Pharmanutra
Next Pharmanutra earnings date
Q4 202615 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)